---
$id: https://graph.org.ai/products/commodity/41181946
$type: Product
source: UNSPSC
code: "41181946"
title: "Gene expression profiling test system for breast cancer prognosis tests"
class: "41181900"
classTitle: "Tumor associated antigen immunological test systems"
family: "41180000"
familyTitle: "Immunological testing systems, components, and supplies"
segment: "41000000"
segmentTitle: "Laboratory and Measuring and Observing and Testing Equipment"


---

# Gene expression profiling test system for breast cancer prognosis tests

**UNSPSC Code**: 41181946
**Class**: [Tumor associated antigen immunological test systems](Tumor associated antigen immunological test systems.mdx)
**Family**: [Immunological testing systems, components, and supplies](../Immunological testing systems, components, and supplies.mdx)
**Segment**: [Laboratory and Measuring and Observing and Testing Equipment](../../Laboratory and Measuring and Observing and Testing Equipment.mdx)

In this classification, a Gene expression profiling test system for breast cancer prognosis tumor associated antigen immunological test system that consists of the reagents used to identify by immunochemical techniques Gene expression profiling test system for breast cancer prognosis based tumors. US FDA regulates Gene expression profiling test system for breast cancer prognosis under 21 CFR 866.6040and under FDA product code NYI.

